Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Speaker
Rumei Chen
National University of Singapore, Singapore
Biography

Chen Rumei received her BSc with academic excellence scholarship from Nan Kai University, China. Upon graduation, she was conferred a full-time PhD research scholarship offered by the Yong Loo Lin School of Medicine in National University of Singapore, Singapore. Her research focus revolves around the profiling of an estrogen-regulated oncogene (TFF3) in CRC and the development of novel therapeutic strategies against it. Meanwhile she has been accredited by Experimental Therapeutics Centre & D3 in Singapore during a course that educate scientists about conducting translational R&D theory and practice. From which, she learnt many practical guidance to translate basic research findings into full-fledged R&D projects. Other than research, Chen has been active in promoting science-related events such as assisting to organize the International Union of Basic and Clinical Pharmacology world conference. She is a member of many international committees, such as European Association for Cancer Research, Pharmacological Society of Singapore.

Abstract

Trefoil Factor 3 (TFF3) expression was observed to be upregulated in colorectal cancer (CRC) and correlated with distant metastasis and poor survival outcomes. The present study investigates the functional role of TFF3 and explores the potential of therapeutic inhibition of TFF3 in CRC alone and in combination with conventional chemotherapy. We demonstrated that the forced expression of TFF3 increased cell viability of CRC cells, being attributed to increased cell cycle S-phase entry and decreased apoptosis. Furthermore, the forced expression of TFF3 enhanced the capacity for foci formation and promoted the cancer stem cell-like behaviour of CRC cells. In contrast, the siRNA-mediated depletion of TFF3 decreased the oncogenicity of CRC cells as indicated by the above parameters. Furthermore, AMPC, a novel and selective small molecule inhibitor of TFF3, has been developed in our laboratory and is used to examine the functional implications of TFF3 inhibition in CRC cells. Consistently, AMPC inhibition of TFF3 in CRC cells resulted in reduction of oncogenic properties. Mechanistically, we demonstrate that the TFF3-stimulated oncogenic behavior of CRC cells is dependent on TFF3 activation of the MAPK/ERK pathway. Besides showing efficacy as a single agent, AMPC when used in combination with 5-fluorouracil (5-FU) exhibited a synergistic inhibitory effect, consistent with our observation that TFF3 depletion increased 5-FU sensitivity in CRC cells. In summary, our study highlights the potential of TFF3 as a therapeutic target in CRC and underscores the potential benefits of its pharmacological inhibition in this cancer using AMPC.

Mail us at

General Enquires
oncology@alliedconferences.org
Queries | Sponsorship | Partnering
oncology@alliedconferences.org
USA/Canada
oncology@alliedconferences.org
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility

The organizers hold no responsibilities or liabilities of the personal articles of attendees at the venue against any kind of theft, loss, damage, due to any reason whatsoever. Delegates are entirely responsible for the safety of their own belongings.

Insurance

No insurance, of any kind, is included along with the registration in any of the events of the organization.

Transportation

Please note that transportation and parking is the responsibility of the registrant, Allied Academies will not be liable for any actions howsoever related to transportation and parking.

Press/Media

Press permission must be obtained from Allied Academies Conference Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party nonprofit organization and this conference is not associated with any commercial meeting company.

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference after payment of complete registration fee. Once registration is complete, please contact oncology@alliedconferences.org to request a personalized letter of invitation, if not received until one month before the scheduled date of the event.

All the bank charges applicable during refund will be deducted from the account of the participant.

Cancellation Policy

All cancellations or modifications of registration must be made in writing to finance@alliedacademies.com

If due to any reason, Allied academies postpone an event on the scheduled date, the participant is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within the period of one year from the date of rescheduling.

Postponement of event

If due to any reason, Allied academies postpone an event and the participant is unable or unwilling to attend the conference on rescheduled dates, he/she is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within the period of one year from the date of rescheduling.

Transfer of registration

All registrations, after payment of complete registration fee, are transferable to other persons from the same organization, if in case the person is unable to attend the event. Request for transfer of registration must be made by the registered person in writing to finance@alliedacademies.com. Details must include the full name of replaced new registrant, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of the conferences.

However, Registration cannot be transferred if intimated within 14 days of the respective conference.

The transferred registrations will not be eligible for Refund.

This cancellation policy was last updated on April 04, 2015.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues are not covered under the cancellation policy of Allied academies, including the inability to obtain a visa.

 Refund Policy:

If the registrant is unable to attend and is not in a position to transfer his/her participation to another person or event, then the following refund policies apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overhead charges, following Refund Policy Orders are available:

  • Before 60 days of the conference: Eligible for Full Refund after deduction of $100 towards service Fee.
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

Accommodation Cancellation Policy:

Accommodation Service Providers (Hotels) have their own cancellation policies which are applicable when cancellations are made less than 30 days prior to arrival. If in case the registrant wishes to cancel or amend the accommodation, he/ she is expected to inform the organizing authorities on a prior basis. Allied academies will advise the registrant to ensure complete awareness of the cancellation policy of your accommodation provider, prior to cancellation or modification of their booking.

Authorization Policy

Please find the information under More in Homepage bar.

Copyright © 2018-2019 Allied Academies, All Rights Reserved.